Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Long-Term Deferred Tax: 2010-2016

Historic Long-Term Deferred Tax for Myriad Genetics (MYGN) over the last 3 years, with Jun 2016 value amounting to $12.7 million.

  • Myriad Genetics' Long-Term Deferred Tax was N/A to $12.7 million in Q2 2016 from the same period last year, while for Jun 2016 it was $12.7 million, marking a year-over-year change of. This contributed to the annual value of $12.7 million for FY2016, which is N/A change from last year.
  • As of Q2 2016, Myriad Genetics' Long-Term Deferred Tax stood at $12.7 million, which was down 5.93% from $13.5 million recorded in Q4 2015.
  • Over the past 5 years, Myriad Genetics' Long-Term Deferred Tax peaked at $30.6 million during Q2 2012, and registered a low of $407,000 during Q1 2015.
  • In the last 3 years, Myriad Genetics' Long-Term Deferred Tax had a median value of $8.0 million in 2014 and averaged $7.5 million.
  • In the last 5 years, Myriad Genetics' Long-Term Deferred Tax grew by 21.93% in 2013 and then tumbled by 88.82% in 2014.
  • Over the past 5 years, Myriad Genetics' Long-Term Deferred Tax (Quarterly) stood at $24.6 million in 2012, then climbed by 21.93% to $30.0 million in 2013, then slumped by 88.82% to $3.2 million in 2014, then reached $13.5 million in 2015, then reached $12.7 million in 2016.
  • Its Long-Term Deferred Tax stands at $12.7 million for Q2 2016, versus $13.5 million for Q4 2015 and $407,000 for Q1 2015.